Marc Louis Copersino, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electroconvulsive Therapy | 2 | 2023 | 472 | 1.200 |
Why?
|
| Psychotherapy, Group | 2 | 2023 | 407 | 1.020 |
Why?
|
| Marijuana Abuse | 7 | 2013 | 402 | 0.980 |
Why?
|
| Substance Withdrawal Syndrome | 8 | 2011 | 633 | 0.860 |
Why?
|
| Cocaine-Related Disorders | 10 | 2010 | 460 | 0.840 |
Why?
|
| Substance-Related Disorders | 12 | 2022 | 4250 | 0.780 |
Why?
|
| Depressive Disorder, Major | 2 | 2023 | 4628 | 0.500 |
Why?
|
| Corpus Striatum | 1 | 2019 | 1220 | 0.450 |
Why?
|
| Disabled Persons | 1 | 2022 | 1209 | 0.420 |
Why?
|
| Cognition Disorders | 4 | 2012 | 4030 | 0.380 |
Why?
|
| Needle Sharing | 1 | 2009 | 24 | 0.360 |
Why?
|
| Anterior Cerebral Artery | 1 | 2009 | 48 | 0.330 |
Why?
|
| Unsafe Sex | 1 | 2009 | 220 | 0.310 |
Why?
|
| Middle Cerebral Artery | 1 | 2009 | 264 | 0.300 |
Why?
|
| Marijuana Smoking | 1 | 2010 | 252 | 0.290 |
Why?
|
| Substance Abuse Treatment Centers | 5 | 2007 | 168 | 0.270 |
Why?
|
| Age Factors | 5 | 2019 | 18355 | 0.260 |
Why?
|
| Neuropsychological Tests | 5 | 2012 | 6974 | 0.250 |
Why?
|
| Methadone | 5 | 2014 | 306 | 0.250 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2009 | 522 | 0.250 |
Why?
|
| Color Perception | 2 | 2007 | 213 | 0.250 |
Why?
|
| Risk-Taking | 1 | 2009 | 986 | 0.230 |
Why?
|
| Self Care | 2 | 2006 | 786 | 0.230 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2012 | 3014 | 0.230 |
Why?
|
| Cannabinoids | 1 | 2006 | 166 | 0.230 |
Why?
|
| Receptors, Opioid, mu | 3 | 2010 | 182 | 0.220 |
Why?
|
| Alcoholism | 5 | 2007 | 1904 | 0.220 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2003 | 68 | 0.220 |
Why?
|
| Cocaine | 6 | 2010 | 1008 | 0.210 |
Why?
|
| Behavior, Addictive | 2 | 2022 | 460 | 0.200 |
Why?
|
| Schizophrenic Psychology | 3 | 2004 | 1677 | 0.200 |
Why?
|
| Semantics | 1 | 2004 | 584 | 0.190 |
Why?
|
| Psychological Tests | 1 | 2003 | 648 | 0.190 |
Why?
|
| Reading | 1 | 2004 | 557 | 0.190 |
Why?
|
| Heroin Dependence | 3 | 2010 | 175 | 0.170 |
Why?
|
| Cognition | 4 | 2023 | 6722 | 0.170 |
Why?
|
| Cerebrovascular Circulation | 1 | 2009 | 2732 | 0.160 |
Why?
|
| Attention | 3 | 2007 | 2396 | 0.160 |
Why?
|
| Adult | 32 | 2023 | 213712 | 0.150 |
Why?
|
| Motivation | 5 | 2013 | 1968 | 0.140 |
Why?
|
| Token Economy | 2 | 2006 | 17 | 0.140 |
Why?
|
| Secondary Prevention | 1 | 2022 | 1520 | 0.130 |
Why?
|
| Reaction Time | 3 | 2014 | 2092 | 0.120 |
Why?
|
| Cannabis | 2 | 2011 | 432 | 0.120 |
Why?
|
| Organ Size | 1 | 2019 | 2253 | 0.120 |
Why?
|
| Electroencephalography | 1 | 2009 | 6142 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 3 | 2007 | 1148 | 0.110 |
Why?
|
| Prescription Drugs | 2 | 2010 | 595 | 0.110 |
Why?
|
| Mass Screening | 3 | 2009 | 5238 | 0.110 |
Why?
|
| Psychotropic Drugs | 3 | 2007 | 893 | 0.110 |
Why?
|
| Humans | 39 | 2023 | 742088 | 0.100 |
Why?
|
| Geriatric Assessment | 1 | 2018 | 1369 | 0.090 |
Why?
|
| Narcotics | 3 | 2007 | 343 | 0.090 |
Why?
|
| Male | 31 | 2019 | 349538 | 0.090 |
Why?
|
| Schizophrenia | 3 | 2004 | 6874 | 0.090 |
Why?
|
| Recurrence | 5 | 2013 | 8333 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2023 | 8297 | 0.090 |
Why?
|
| Opiate Substitution Treatment | 1 | 2014 | 404 | 0.090 |
Why?
|
| Fentanyl | 3 | 2010 | 410 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 6030 | 0.090 |
Why?
|
| Brain | 4 | 2010 | 26343 | 0.090 |
Why?
|
| Heroin | 1 | 2010 | 117 | 0.090 |
Why?
|
| Comorbidity | 5 | 2007 | 10372 | 0.090 |
Why?
|
| Female | 30 | 2019 | 379592 | 0.080 |
Why?
|
| Self Disclosure | 1 | 2009 | 251 | 0.080 |
Why?
|
| Fourier Analysis | 1 | 2009 | 447 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2023 | 62966 | 0.080 |
Why?
|
| Psychomotor Performance | 2 | 2014 | 1895 | 0.080 |
Why?
|
| Computational Biology | 1 | 2019 | 3518 | 0.070 |
Why?
|
| Analysis of Variance | 4 | 2011 | 6365 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2009 | 292 | 0.070 |
Why?
|
| ROC Curve | 2 | 2018 | 3528 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2013 | 2372 | 0.070 |
Why?
|
| Middle Aged | 18 | 2018 | 213127 | 0.070 |
Why?
|
| Tranquilizing Agents | 1 | 2006 | 59 | 0.070 |
Why?
|
| Verbal Behavior | 1 | 2007 | 339 | 0.070 |
Why?
|
| Depressive Disorder | 1 | 2018 | 3748 | 0.060 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2007 | 422 | 0.060 |
Why?
|
| Blood Flow Velocity | 1 | 2009 | 1423 | 0.060 |
Why?
|
| Trauma Centers | 2 | 2007 | 889 | 0.060 |
Why?
|
| Clinical Trials as Topic | 3 | 2010 | 7901 | 0.060 |
Why?
|
| Wounds and Injuries | 2 | 2007 | 2400 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2013 | 2051 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2970 | 0.060 |
Why?
|
| Opioid-Related Disorders | 4 | 2010 | 2062 | 0.060 |
Why?
|
| Behavior Therapy | 2 | 2007 | 866 | 0.060 |
Why?
|
| Analgesics, Opioid | 3 | 2010 | 3667 | 0.060 |
Why?
|
| HIV Infections | 1 | 2009 | 16678 | 0.060 |
Why?
|
| Discrimination Learning | 1 | 2004 | 280 | 0.050 |
Why?
|
| Disease Progression | 1 | 2019 | 13256 | 0.050 |
Why?
|
| Culture | 1 | 2007 | 632 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2008 | 1048 | 0.050 |
Why?
|
| Depression | 1 | 2021 | 7733 | 0.050 |
Why?
|
| Cues | 1 | 2007 | 868 | 0.050 |
Why?
|
| Coffee | 1 | 2006 | 578 | 0.050 |
Why?
|
| Sex Factors | 3 | 2010 | 10392 | 0.050 |
Why?
|
| Verbal Learning | 2 | 2000 | 466 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2006 | 13921 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2022 | 778 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 14720 | 0.040 |
Why?
|
| Health Surveys | 1 | 2009 | 4030 | 0.040 |
Why?
|
| Smoking | 2 | 2006 | 8969 | 0.040 |
Why?
|
| Positron-Emission Tomography | 4 | 2010 | 6259 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 15056 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2006 | 1158 | 0.040 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2011 | 1953 | 0.040 |
Why?
|
| Ambulatory Care | 2 | 2007 | 2706 | 0.040 |
Why?
|
| Adolescent | 8 | 2018 | 85649 | 0.040 |
Why?
|
| Sickness Impact Profile | 1 | 2018 | 304 | 0.040 |
Why?
|
| Psychotherapy | 1 | 2005 | 1644 | 0.030 |
Why?
|
| Baltimore | 2 | 2007 | 231 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2007 | 2527 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 3611 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 19862 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2008 | 6440 | 0.030 |
Why?
|
| Consensus | 1 | 2022 | 2935 | 0.030 |
Why?
|
| Social Desirability | 1 | 2013 | 47 | 0.030 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 2 | 2007 | 295 | 0.030 |
Why?
|
| Substance Abuse Detection | 2 | 2006 | 283 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2006 | 3957 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2007 | 3839 | 0.030 |
Why?
|
| United States | 5 | 2007 | 69693 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2010 | 24913 | 0.030 |
Why?
|
| Socioeconomic Factors | 3 | 2011 | 7770 | 0.020 |
Why?
|
| Longevity | 1 | 2018 | 1069 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2010 | 379 | 0.020 |
Why?
|
| Memory | 1 | 2000 | 2163 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 10943 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2011 | 77098 | 0.020 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2010 | 230 | 0.020 |
Why?
|
| Aged | 4 | 2018 | 162944 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 2 | 2009 | 2714 | 0.020 |
Why?
|
| Mental Disorders | 2 | 2007 | 6587 | 0.020 |
Why?
|
| Philosophy, Medical | 1 | 2007 | 79 | 0.020 |
Why?
|
| Self Concept | 1 | 2013 | 1025 | 0.020 |
Why?
|
| Young Adult | 4 | 2018 | 56350 | 0.020 |
Why?
|
| Residential Treatment | 1 | 2007 | 111 | 0.020 |
Why?
|
| Linear Models | 2 | 2008 | 5948 | 0.020 |
Why?
|
| Putamen | 1 | 2007 | 291 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2009 | 975 | 0.020 |
Why?
|
| Caudate Nucleus | 1 | 2007 | 393 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2013 | 1423 | 0.020 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2005 | 67 | 0.020 |
Why?
|
| Unemployment | 1 | 2007 | 214 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2007 | 571 | 0.020 |
Why?
|
| Accreditation | 1 | 2007 | 449 | 0.020 |
Why?
|
| Protein Binding | 2 | 2008 | 9387 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2005 | 468 | 0.020 |
Why?
|
| Methamphetamine | 1 | 2005 | 152 | 0.010 |
Why?
|
| Models, Organizational | 1 | 2007 | 574 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3510 | 0.010 |
Why?
|
| Mental Recall | 2 | 2000 | 1205 | 0.010 |
Why?
|
| Professional Competence | 1 | 2007 | 448 | 0.010 |
Why?
|
| Alcohol-Related Disorders | 1 | 2006 | 234 | 0.010 |
Why?
|
| Long QT Syndrome | 1 | 2008 | 453 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2010 | 2536 | 0.010 |
Why?
|
| Psychometrics | 2 | 2004 | 2999 | 0.010 |
Why?
|
| Confidentiality | 1 | 2007 | 609 | 0.010 |
Why?
|
| Psychology | 1 | 2004 | 355 | 0.010 |
Why?
|
| Diffusion of Innovation | 1 | 2007 | 725 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2008 | 1407 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2007 | 719 | 0.010 |
Why?
|
| Professional-Patient Relations | 1 | 2007 | 736 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 15530 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 2008 | 1669 | 0.010 |
Why?
|
| Dopamine | 1 | 2007 | 1589 | 0.010 |
Why?
|
| Serial Learning | 1 | 2000 | 45 | 0.010 |
Why?
|
| Mood Disorders | 1 | 2007 | 1106 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2007 | 2451 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2014 | 12017 | 0.010 |
Why?
|
| Prevalence | 2 | 2007 | 15194 | 0.010 |
Why?
|
| Ethanol | 1 | 2006 | 1337 | 0.010 |
Why?
|
| Forecasting | 1 | 2008 | 2948 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2009 | 6452 | 0.010 |
Why?
|
| Educational Status | 1 | 2007 | 2533 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 57683 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2005 | 2290 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 4214 | 0.010 |
Why?
|
| Data Collection | 1 | 2007 | 3339 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2007 | 2211 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2008 | 39004 | 0.010 |
Why?
|
| Urban Population | 1 | 2004 | 2018 | 0.010 |
Why?
|
| Time Factors | 2 | 2008 | 40054 | 0.010 |
Why?
|
| Pain | 1 | 2010 | 4961 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 12958 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2007 | 3527 | 0.010 |
Why?
|
| Anxiety | 1 | 2007 | 4279 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2006 | 3203 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 3915 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2010 | 35342 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2005 | 6669 | 0.010 |
Why?
|
| Acute Disease | 1 | 2000 | 7141 | 0.010 |
Why?
|
| Incidence | 1 | 2007 | 20928 | 0.010 |
Why?
|
| Neurons | 1 | 2007 | 9325 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 8925 | 0.000 |
Why?
|
| Hospitalization | 1 | 2007 | 10232 | 0.000 |
Why?
|
| Risk Factors | 1 | 2007 | 72145 | 0.000 |
Why?
|